Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN study supporting a slowing decline…
Independent audits and a Platinum CyberVadis rating demonstrate the rigor, resilience, and maturity of the OPUS platform—the industry's secure, audit-ready…
Samsung TV aims to be the first to launch Google Photos features in 2026, debuting with memories on the big…
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name…
December 23, 2025 06:01 ET | Source: Radware Ltd. TEL AVIV, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ:…
GUANGZHOU, China, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a…
The secondary analysis of the PACE trial highlights the value of counting Circulating Tumor Cells (CTCs) in the blood to…
In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine therapy in combination settings, as…
– Company to host live webcast and conference call Monday, December 15, 2025 at 8:00 am ET – December 14,…
LUXEMBOURG and PARIS, Dec. 10, 2025 /PRNewswire/ -- FitLine is proud to announce a new partnership with Paris Basketball, the…